Clinical trial
The Yellow Fever Vaccine Immunity in HIV Infected Patients: Studies of Immunological Responses at 10 Years (ANRS 0146s NovaaTen)
NCT05450770 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Yellow Fever Vaccine Immunity in HIV Infected Patients: Studies of Immunological Responses at 10 Years (ANRS 0146s NovaaTen)
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 1, 2024
- Completion date
- November 1, 2024
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.